{
    "clinical_study": {
        "@rank": "151351", 
        "arm_group": [
            {
                "arm_group_label": "AKB-6548", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the hemoglobin response (efficacy), safety, and\n      tolerability of orally administered AKB-6548 in patients with Chronic Kidney Disease\n      (pre-dialysis) with anemia with dosing for 20 weeks."
        }, 
        "brief_title": "20-Week Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Anemia", 
            "Chronic Kidney Disease"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Anemia", 
                "Kidney Diseases", 
                "Renal Insufficiency, Chronic", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Key Inclusion Criteria:\n\n          -  18 to 82 years of age, inclusive\n\n          -  Chronic Kidney Disease with a GFR category of G3a-G5 and not yet on dialysis\n\n          -  eGFR \u2265 10 and \u2264 65 mL/minute/1.73 m2\n\n          -  Anemia secondary to CKD with an ESA status and a Screening HGB as per protocol\n\n          -  Iron replete with ferritin and TSAT levels as defined per protocol\n\n        Key Exclusion Criteria:\n\n          -  BMI > 44.0 kg/m2\n\n          -  Red blood cell transfusion within 11 weeks prior to the Screening visit\n\n          -  Androgen therapy within the previous 21 days prior to the Screening visit\n\n          -  Intravenous iron within the past 4 weeks prior to the Screening visit\n\n          -  AST or ALT >1.8x ULN, alkaline phosphatase >2x ULN, or total bilirubin >1.5x ULN\n\n          -  Screening ECG with QTc > 500 msec\n\n          -  Uncontrolled hypertension\n\n          -  Class III or IV congestive heart failure\n\n          -  Myocardial infarction, acute coronary syndrome, or stroke within 6 months prior to\n             the Screening visit"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "82 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01906489", 
            "org_study_id": "AKB-6548-CI-0007"
        }, 
        "intervention": [
            {
                "arm_group_label": "AKB-6548", 
                "description": "Oral dose administered once daily for 20 weeks.  Dose adjustment based on hemoglobin level as defined in the protocol.", 
                "intervention_name": "AKB-6548", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Oral placebo administered once daily for 20 weeks.  Dose adjustment based on hemoglobin level as defined in the protocol.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "anemia", 
            "chronic kidney disease", 
            "CKD", 
            "chronic renal insufficiency", 
            "renal impairment", 
            "erythropoietin", 
            "kidney", 
            "oral anemia treatment", 
            "hemoglobin", 
            "hypoxia-inducible factor", 
            "HIF", 
            "hypoxia-inducible factor prolyl-hydroxylase inhibitor", 
            "HIF-PHI", 
            "efficacy", 
            "safety", 
            "pharmacokinetics"
        ], 
        "lastchanged_date": "May 19, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Glendale", 
                        "country": "United States", 
                        "state": "Arizona"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tucson", 
                        "country": "United States", 
                        "state": "Arizona"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Azusa", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chula Vista", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Downey", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "El Centro", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Mesa", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Long Beach", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Riverside", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sacramento", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Arvada", 
                        "country": "United States", 
                        "state": "Colorado"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Westminster", 
                        "country": "United States", 
                        "state": "Colorado"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lauderdale Lakes", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Port Charlotte", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Augusta", 
                        "country": "United States", 
                        "state": "Georgia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Macon", 
                        "country": "United States", 
                        "state": "Georgia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Meridian", 
                        "country": "United States", 
                        "state": "Idaho"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Evergreen Park", 
                        "country": "United States", 
                        "state": "Illinois"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lafayette", 
                        "country": "United States", 
                        "state": "Louisiana"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shreveport", 
                        "country": "United States", 
                        "state": "Louisiana"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lansing", 
                        "country": "United States", 
                        "state": "Michigan"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Petoskey", 
                        "country": "United States", 
                        "state": "Michigan"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pontiac", 
                        "country": "United States", 
                        "state": "Michigan"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Farmington", 
                        "country": "United States", 
                        "state": "Missouri"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Missouri"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Vegas", 
                        "country": "United States", 
                        "state": "Nevada"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albuquerque", 
                        "country": "United States", 
                        "state": "New Mexico"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Flushing", 
                        "country": "United States", 
                        "state": "New York"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mineola", 
                        "country": "United States", 
                        "state": "New York"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Rochelle", 
                        "country": "United States", 
                        "state": "New York"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rosedale", 
                        "country": "United States", 
                        "state": "New York"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Asheville", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rocky Mount", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wilmington", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbia", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Knoxville", 
                        "country": "United States", 
                        "state": "Tennessee"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Arlington", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edinburg", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint George", 
                        "country": "United States", 
                        "state": "Utah"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase 2b Randomized, Double-Blind, Placebo-Controlled Study to Assess the Pharmacodynamic Response, Safety, and Tolerability to 20 Weeks of Oral Dosing of AKB-6548 in Subjects With Anemia Secondary to Chronic Kidney Disease (CKD), GFR Categories G3a-G5 (Stages 3, 4, AND 5) (Pre-Dialysis)", 
        "other_outcome": [
            {
                "measure": "Iron metabolism to include actual values and change from baseline in iron indices.", 
                "safety_issue": "No", 
                "time_frame": "20 weeks"
            }, 
            {
                "measure": "Iron utilization (both oral and intravenous).", 
                "safety_issue": "No", 
                "time_frame": "20 weeks"
            }, 
            {
                "measure": "Concentration measurements of AKB-6548 and metabolites.", 
                "safety_issue": "Yes", 
                "time_frame": "Weeks 12 and 20 visits"
            }, 
            {
                "measure": "Neurocognitive and patient reported outcome measures.", 
                "safety_issue": "No", 
                "time_frame": "20 weeks"
            }
        ], 
        "overall_official": {
            "affiliation": "Akebia Therapeutics", 
            "last_name": "Robert Shalwitz, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Percent of subjects achieving or maintaining a hemoglobin response as defined in the protocol.", 
            "safety_issue": "No", 
            "time_frame": "20 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01906489"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Analysis/reanalysis of the primary endpoint with regard to hemoglobin control, need for rescue, baseline hemoglobin, and protocol-defined study groups.", 
                "safety_issue": "No", 
                "time_frame": "20 weeks"
            }, 
            {
                "measure": "Hematologic response to include actual values and change from baseline in hematologic parameters.", 
                "safety_issue": "No", 
                "time_frame": "20 weeks"
            }, 
            {
                "measure": "Need for transfusion and/or ESA rescue.", 
                "safety_issue": "No", 
                "time_frame": "20 weeks"
            }, 
            {
                "measure": "Safety and tolerability measures to include assessments of adverse events, vital signs, ECGs, and laboratory assay results.", 
                "safety_issue": "Yes", 
                "time_frame": "20 weeks of therapy, 4 week follow-up"
            }
        ], 
        "source": "Akebia Therapeutics", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Akebia Therapeutics", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}